These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32669644)

  • 1. The effect of prolonged tracheal intubation on the association between patent ductus arteriosus and bronchopulmonary dysplasia (grades 2 and 3).
    Clyman RI; Hills NK
    J Perinatol; 2020 Sep; 40(9):1358-1365. PubMed ID: 32669644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial.
    Clyman RI; Kaempf J; Liebowitz M; Erdeve O; Bulbul A; Håkansson S; Lindqvist J; Farooqi A; Katheria A; Sauberan J; Singh J; Nelson K; Wickremasinghe A; Dong L; Hassinger DC; Aucott SW; Hayashi M; Heuchan AM; Carey WA; Derrick M; Fernandez E; Sankar M; Leone T; Perez J; Serize A;
    J Pediatr; 2021 Feb; 229():283-288.e2. PubMed ID: 32979387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia.
    Clyman RI; Hills NK; Cambonie G; Debillon T; Ligi I; Gascoin G; Patkai J; Beuchee A; Favrais G; Durrmeyer X; Flamant C; Rozé JC
    Pediatr Res; 2022 Feb; 91(3):652-658. PubMed ID: 33790415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
    Nawaytou H; Hills NK; Clyman RI
    Pediatr Res; 2023 Aug; 94(2):547-554. PubMed ID: 36804505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks.
    Clyman RI; Hills NK; Liebowitz M; Johng S
    Am J Perinatol; 2020 Jan; 37(2):216-223. PubMed ID: 31600791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
    Gentle SJ; Travers CP; Clark M; Carlo WA; Ambalavanan N
    Am J Respir Crit Care Med; 2023 Apr; 207(7):921-928. PubMed ID: 36378949
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
    Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
    Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
    Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M; Clyman RI
    J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Hemodynamically Significant Patent Ductus Arteriosus and Bronchopulmonary Dysplasia.
    Schena F; Francescato G; Cappelleri A; Picciolli I; Mayer A; Mosca F; Fumagalli M
    J Pediatr; 2015 Jun; 166(6):1488-92. PubMed ID: 25882876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.
    Willis KA; Weems MF
    Congenit Heart Dis; 2019 Jan; 14(1):27-32. PubMed ID: 30343505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
    Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
    JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent ductus arteriosus (PDA) and pulmonary morbidity: can early targeted pharmacologic PDA treatment decrease the risk of bronchopulmonary dysplasia?
    Clyman RI; Hills NK
    Semin Perinatol; 2023 Mar; 47(2):151718. PubMed ID: 36882361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchopulmonary dysplasia in the newborn infant. Occurrence of bronchopulmonary dysplasia in the severe neonatal respiratory syndrome complicated by patent ductus arteriosus treated with mechanical ventilation, in newborn infants of gestational age under 36 weeks].
    Silvestri G; Tuo P; Soliani M; Moretti R; Nahum L; Ivani G
    Minerva Pediatr; 1984 Feb; 36(4):163-8. PubMed ID: 6738469
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
    Villamor E; van Westering-Kroon E; Gonzalez-Luis GE; Bartoš F; Abman SH; Huizing MJ
    JAMA Netw Open; 2023 Nov; 6(11):e2345299. PubMed ID: 38015504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for moderate/severe bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks: a multicenter retrospective analysis].
    Jiangsu Province Neonatal Perinatal Cooperation Network
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1104-1110. PubMed ID: 36305110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g].
    Huang J; Lin XZ; Zheng Z; Wang L; Ou FF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1326-1333. PubMed ID: 36544414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity.
    Clyman RI
    Semin Perinatol; 2018 Jun; 42(4):235-242. PubMed ID: 29958703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
    Mirza H; Garcia J; McKinley G; Hubbard L; Sensing W; Schneider J; Oh W; Wadhawan R
    J Perinatol; 2019 Dec; 39(12):1648-1655. PubMed ID: 31554913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.